# The impact of brain-derived neurotrophic factor gene polymorphisms on post-stroke naming in aphasia

## TL;DR

This study explores how a genetic variation in the brain-derived neurotrophic factor gene affects language recovery after stroke.

## Contribution

The study investigates the role of the rs6265 polymorphism in BDNF gene on chronic naming recovery in post-stroke aphasia.

## Key findings

- Individuals with the common BDNF polymorphism had a 33% higher likelihood of high chronic naming scores.
- Those with the typical polymorphism showed a 24% higher likelihood of recovering from poor acute naming performance.
- BDNF genotype was not a significant independent predictor of recovery outcomes.

## Abstract

Post-stroke aphasia, or language deficits after stroke, afflicts 20–30% of survivors and often persists into the chronic phase. The protein brain-derived neurotrophic factor has been identified as important for neuroplasticity, and is regulated by the brain-derived neurotrophic factor gene. A patient’s brain-derived neurotrophic factor genotype may influence their post-stroke aphasia recovery. This study aimed to investigate the impact of a single nucleotide polymorphism in the brain-derived neurotrophic factor gene, rs6265, on language recovery. We hypothesized that individuals with the most common polymorphism would exhibit better chronic naming performance and a more favorable recovery trajectory from poor acute performance to strong chronic outcomes compared to those without the polymorphism. We retrospectively analyzed data from 77 participants with post-stroke aphasia from three recent or ongoing studies that included both repeated standardized picture naming assessments in the acute, subacute, and chronic phases and brain-derived neurotrophic factor genotyping. Statistical analyses controlled for acute performance and lesion volume when evaluating the effect of brain-derived neurotrophic factor genotype on the probability of better chronic language recovery (Aim 1) and on the probability of a person with poor acute performance later having strong performance in the subacute to chronic period (Aim 2). Results indicated that those with the most common polymorphism had a 33% higher likelihood of high naming scores in the chronic phase compared to those with the with less common polymorphisms (with a methionine allele). Individuals with the typical polymorphism whose acute naming was below average after stroke exhibited a 24% higher likelihood of recovering to be above average. Brain-derived neurotrophic factor status was not a significant independent predictor of outcome in either model. Our results suggest that the effect of brain-derived neurotrophic factor polymorphisms on chronic post-stroke aphasia recovery is, at best, modest and underscores the importance of individualized approaches to neurorehabilitation.